albendazole has been researched along with Heart Defects, Congenital in 1 studies
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Using the anthelmintic drug albendazole as a model substance, we demonstrated stage-dependent toxic effects at three windows of zebrafish embryo development, i." | 1.38 | Albendazole causes stage-dependent developmental toxicity and is deactivated by a mammalian metabolization system in a modified zebrafish embryotoxicity test. ( Mattsson, A; Oskarsson, A; Patring, J; Ullerås, E, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mattsson, A | 1 |
| Ullerås, E | 1 |
| Patring, J | 1 |
| Oskarsson, A | 1 |
1 other study available for albendazole and Heart Defects, Congenital
| Article | Year |
|---|---|
Albendazole causes stage-dependent developmental toxicity and is deactivated by a mammalian metabolization system in a modified zebrafish embryotoxicity test.
Topics: Albendazole; Animals; Anthelmintics; Cytochrome P450 Family 2; Embryo, Nonmammalian; Embryonic Devel | 2012 |